Xopenex Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Xopenex General Information
Description
Provider of healthcare services. The company manufactures a pharmaceutical under the Xopenex brand which is used in the treatment and prevention of bronchospasm in adults, adolescents and children.
Contact Information
Corporate Office
- 84 Waterford Drive
- Marlborough, MA 01752
- United States
Corporate Office
- 84 Waterford Drive
- Marlborough, MA 01752
- United States
Xopenex Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Xopenex Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Xopenex FAQs
-
Where is Xopenex headquartered?
Xopenex is headquartered in Marlborough, MA.
-
What industry is Xopenex in?
Xopenex’s primary industry is Pharmaceuticals.
-
Is Xopenex a private or public company?
Xopenex is a Private company.
-
What is the current valuation of Xopenex?
The current valuation of Xopenex is .
-
What is Xopenex’s current revenue?
The current revenue for Xopenex is .
-
Who are Xopenex’s investors?
Sunovion Pharmaceuticals has invested in Xopenex.
-
When was Xopenex acquired?
Xopenex was acquired on 30-Sep-2014.
-
Who acquired Xopenex?
Xopenex was acquired by Akorn.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
